Abstract: Extrudable compositions were prepared comprising poly(propylene) and a liquid additive comprising a lactam group. The compositions can comprise other optional additives that include a polyhemiaminal, antioxidants, UV light absorbers, and surfactants. The extruded compositions have higher percent elongation at break and lower Young's modulus compared to extruded poly(propylene) lacking the liquid additive. These and other property improvements make the extruded compositions attractive for forming field joint coatings for undersea pipeline applications.

Abstract: Extrudable compositions were prepared comprising poly(propylene) and a liquid additive comprising a lactam group. The compositions can comprise other optional additives that include a polyhemiaminal, antioxidants, UV light absorbers, and surfactants. The extruded compositions have higher percent elongation at break and lower Young's modulus compared to extruded poly(propylene) lacking the liquid additive. These and other property improvements make the extruded compositions attractive for forming field joint coatings for undersea pipeline applications.

Abstract: An electronic vehicle stability control system includes a hydraulic braking circuit having a plurality of electronically controlled valves, a plurality of pumps, a motor that operates the plurality of pumps, and a suction throttle valve that throttles flow of hydraulic fluid to at least one of the plurality of pumps. The electronic vehicle stability control system also includes a controller coupled to the hydraulic braking circuit that controls the plurality of electronically controlled valves.

Abstract: Advances in robot performance have been limited by a lack of advances in the mature field of battery technology. The focus of robotic power systems must expand from the use of single energy devices to the inclusion of multiple devices which can be optimized for a robotic platform. The challenge lies in the development of the hardware and control algorithms for a scalable power delivery architecture which satisfies the power and energy requirements of most unmanned ground vehicles. This invention is directed to an architecture which is easily scalable and facilitates the use of a wide variety of energy storage/generation devices, while focusing on the system control algorithm and its stability. The experimental results for an example system are presented demonstrating that the architecture functions properly when faced with real world robotic power demands.

Abstract: The present invention relates to the use of nucleoside derivatives of formula Ia wherein the symbols are as defined in the specification, and of pharmaceutically acceptable salts thereof and to pharmaceutical compositions containing such compounds.

Abstract: The present invention relates to the use of nucleoside derivatives of formula Ia wherein the symbols are as defined in the specification, and of pharmaceutically acceptable salts thereof and to pharmaceutical compositions containing such compounds.

Abstract: Advances in robot performance have been limited by a lack of advances in the mature field of battery technology. The focus of robotic power systems must expand from the use of single energy devices to the inclusion of multiple devices which can be optimized for a robotic platform. The challenge lies in the development of the hardware and control algorithms for a scalable power delivery architecture which satisfies the power and energy requirements of most unmanned ground vehicles. This invention is directed to an architecture which is easily scalable and facilitates the use of a wide variety of energy storage/generation devices, while focusing on the system control algorithm and its stability. The experimental results for an example system are presented demonstrating that the architecture functions properly when faced with real world robotic power demands.

Abstract: The present invention relates to the use of nucleoside derivatives of formula I wherein B signifies a 9-purinyl residue B1 of formula or a 1-pyrimidyl residue B2 of formula wherein the symbols are as defined in the specification, and of pharmaceutically acceptable salts thereof; for the treatment of diseases mediated by the Hepatitis C Virus (HCV), for the preparation of a medicament for such treatment and to pharmaceutical compositions containing such compounds.

Abstract: The present invention relates to the use of nucleoside derivatives of formula Ia wherein the symbols are as defined in the specification, and of pharmaceutically acceptable salts thereof and to pharmaceutical compositions containing such compounds.

Abstract: Methods and systems for supplying auxiliary electrical power to a controller during power loss are described hereinabove. The system is powered by a primary power source, and includes a controller and a winding load that are both powered by the primary power source, and a switching device. When the primary power source is disconnected from the controller and winding load, the winding load continues to residually exercise to generate residual electrical power. The second switching device then channels the residual electrical power to the controller for a period of time at an acceptable level.

Abstract: The present invention relates to the use of nucleoside derivatives of formula Ia wherein the symbols are as defined in the specification, and of pharmaceutically acceptable salts thereof which inhibit HCV polymerase and are useful for treating a patient suffering from a HCV infection and to pharmaceutical compositions containing such compounds.

Abstract: The present invention relates to the use of nucleoside derivatives of formula Ia wherein the symbols are as defined in the specification, and of pharmaceutically acceptable salts thereof and to pharmaceutical compositions containing such compounds.

Abstract: The present invention relates to the use of nucleoside derivatives of formula Ia wherein the symbols are as defined in the specification, and of pharmaceutically acceptable salts thereof and to pharmaceutical compositions containing such compounds.

Abstract: The present invention relates to the use of nucleoside derivatives of formula I wherein B signifies a 9-purinyl residue B1 of formula or a 1-pyrimidyl residue B2 of formula wherein the symbols are as defined in the specification, and of pharmaceutically acceptable salts thereof; for the treatment of diseases mediated by the Hepatitis C Virus (HCV), for the preparation of a medicament for such treatment and to pharmaceutical compositions containing such compounds.

Abstract: Methods and systems for supplying auxiliary electrical power to a controller during power loss are described hereinabove. The system is powered by a primary power source, and includes a controller and a winding load that are both powered by the primary power source, and a switching device. When the primary power source is disconnected from the controller and winding load, the winding load continues to residually exercise to generate residual electrical power. The second switching device then channels the residual electrical power to the controller for a period of time at an acceptable level.

Abstract: Packaging and processes for facilitating fast, efficient, and reliable production line packaging of products, and more particularly perishable products including meat products. Product trays according to the present invention are formed of non-foam plastic material with three dimensional structure and configuration that imparts an esthetically pleasing appearance and feel to the customer at the point of sale, as well as offering to the consumer a container that is microwavable, dishwasher safe and freezer safe in addition, if desired, to being recyclable. Such packaging and processes are particularly useful in newly emerging automated supply chains where inventory sales are tracked to support centralized processing of meat and other perishable products at centralized facilities for shipment to geographically distant points of safe.

Abstract: A process is provided for the manufacture of liquid polysulfide polymers. In particular, the process allows for making the liquid form of the polysulfide polymer directly and eliminates the need to first make a solid polysulfide polymer and then convert it to a liquid.

Abstract: A hand-held drinking container for consuming liquids, particularly while a user is engaged in physical activity, such as running, walking or in-line skating. One liquid reservoir (1) forms both the main body (27) and the handle (6) of the container. The user turns a trigger (3) on the outside of the handle (6) so as to enable an internal triggering mechanism (10) to lower a sealer (11) to permit liquid to exit the container via the funnel spout (2) on top of the container. Cushion supports (4) located on the main body (27) press against a back side of the user's hand to allow the user to focus his or her attention on the activity rather than on constantly gripping the container. One or more optional weights (7) can be secured to the bottom of the container by using straps (8) to enhance a workout. An optional flashlight (28) may be secured as well to provide safety for those who prefer exercising when dark.

Abstract: In a vacuum pump of the regenerative type or including a regenerative section in which a rotatable vertical shaft is supported by upper and lower bearings, a lubricating system for lubricating the upper bearing comprising an axial bore extending along the shaft and communicating at its upper end with at least one oil hole in alignment with the upper bearing, the lower open end of the axial bore extending in to a shaft reservoir located in a sump for containing lubricating fluid, the arrangement being such that centrifugal force generated by the rotation of the shaft will cause the lubricating fluid in the shaft reservoir to pass along the axial bore as a thin film towards the oil hole and hence to the upper bearing, in which at least one port is formed in a wall of the shaft reservoir to permit the passage of lubricating fluid therethrough from the sump in a controlled manner dependent upon the head of lubricating fluid in the sump above the port.

Abstract: The present invention relates to the use of nucleoside derivatives of formula I 1